Therefore, the suppression of IL-23 by Cal and Cal/BDP may contribute to correcting the imbalance between CD4+ Tregs and proinflammatory T17 cells in the dLNs, leading to a long-term clinical response of psoriasis. The gene discussed is IL23A; the disease is psoriasis.